Sandra Ekstedt has joined Oxcia as Senior Scientist, a very welcome reinforcement as Sandra has a strong background in inflammation, immunology and airway disease with a PhD and over 10 years of work in the field. Sandra will primarily work with OXC-201, Oxcias exciting project for Idiopathic pulmonary fibrosis (IPF), but will also be of great value for Oxcias other projects with promising potential in this area. Sandra comes most recently from Karolinska Institute (KI) and will in her role work very closely with KI, progressing the knowledge and further development of OXC-201.
Latest news
-
Oxcia AB (publ) (“Oxcia”) har idag offentliggjort årsredovisningen för 2022.
-
Oxcia AB (publ) (“Oxcia”) has today published the annual report for 2022.
-
Aktieägarna i Oxcia AB, org.nr 556932–4717, (”Bolaget”) kallas till årsstämma tisdagen den 13 juni 2023 klockan 17:00 i Life city, Solnavägen 3, Solna. Rätt att deltaga samt anmälan Rätt att delta i stämman har den som är registrerad som… Continue reading Kallelse till årsstämma i Oxcia AB (publ) den 13 juni 2023